Sandoz: Healthcare is a right. Access is the work.
We celebrate medical breakthroughs, but often
overlook the work required to make them available to people. Richard Saynor, CEO of Sandoz, the global leader in affordable medicine, and Tripti Jha, Sandoz Chief People Officer, explore why access remains one of the world's biggest healthcare challenges. Using the story of penicillin and examples from across Africa, they show how it takes leadership and persistence to turn scientific progress into better health outcomes.
Speakers
-
Tripti JhaCPOTripti Jha
CPO
Tripti Jha has been Chief People Officer since 2023, having worked most recently as chief talent and transformation officer at Novartis. She brings over 23 years of experience and a proven track record in driving impactful human resources strategy, developing people and organisation culture. She also brings extensive experience of working with executive committees and boards of directors. Previously, she held various senior, global and country or site-level positions within the Novartis group. Prior to joining Novartis, she worked with CARE, a leading humanitarian global organisation on improving access to healthcare for underserved and underprivileged sections of society. She graduated with a master of arts degree in social work from Tata Institute of Social Sciences, India, and served as president of the Students’ Union at Miranda House, University of Delhi.
-
Richard SaynorCEORichard Saynor
CEO
Richard Saynor has led Sandoz since 2019, offering a proven track record as a senior leader in both innovation-driven and generics/biosimilars pharmaceutical companies. Prior to joining Sandoz, he was senior vice president for classic & established products, commercial & digital platforms at GSK. Previously he served in several commercial senior leadership roles at Sandoz. Richard Saynor is a pharmacist by training and began his pharmaceutical business career as a sales representative at G.D. Searle in the UK. He earned his bachelor’s degree in pharmacy from the University of Bradford, UK. Richard Saynor currently serves as the inaugural chair of the CEO Advisory Committee of the International Generics & Biosimilars Association (IGBA).